FindMyRecallSubscribe
Class I: serious health riskTerminated

Abrams Royal Pharmacy Lidocaine 18 Recall

Lidocaine 18

Abrams Royal Pharmacy · Dallas, TX

Risk level
Class I
Reported by FDA
Nov 26, 2014
Recall ID
D-0251-2015
Check your lot numberHow we source this data

Summary

Abrams Royal Pharmacy recalled Lidocaine 18 starting Apr 19, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-0251-2015 on Nov 26, 2014. Reason: Non-Sterility. Status: Terminated.

Why it was recalled

Non-Sterility

Product description

Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX

Lot numbers, UPCs & expiration codes

Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013

Where it was sold

Texas

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0251-2015
Classification
Class I
Status
Terminated
Recall initiated
Apr 19, 2013
FDA report date
Nov 26, 2014
Quantity
50 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Abrams Royal Pharmacy

Original FDA data

Every field from FDA enforcement report D-0251-2015, exactly as published.

Show all FDA fields
City
Dallas
State
TX
Status
Terminated
Country
United States
Event ID
68342
Address
8220 Abrams Rd
Code information
Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013
Postal code
75231-1402
Report date
Nov 26, 2014
Product type
Drugs
Recall number
D-0251-2015
Classification
Class I
Recalling firm
Abrams Royal Pharmacy
Product quantity
50 syringes
Termination date
Oct 7, 2016
Reason for recall
Non-Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX
Distribution pattern
Texas
Recall initiation date
Apr 19, 2013
Initial firm notification
Telephone
Center classification date
Nov 17, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0251-2015, published Nov 26, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls